Mebendazole

甲苯达唑

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameMebendazole
Drug Alias Namemebendazol甲苯咪唑Mebendazolum甲苯哒唑Vermox +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated proteins inhibitors
TargetsMicrotubule-associated proteins
Therapy Area/IndicationsGastrointestinal NeoplasmsNeoplasmsNecatoriasis +[8] 
Global Approved IndicationsHookworm InfectionsEnterobiasisAscariasis +[4] 
Approved Indications in ChinaEnterobiasisAscariasis
Original Approved Country/TerritoryUnited States
Original Approved Date1974/06/28
Country/TerritoryBelgiumUnited StatesSweden +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesBullFrog AI Holdings IncXian Janssen Pharmaceutical LtdGuilin Pharmaceutical Co Ltd
Inactive CompaniesJanssen Pharmaceuticals IncSwiss Tropical & Public Health InstituteUniversity Of Kelaniya Alumni Association Nsw And Act Incorporated +[5] 
Active IndicationsEnterobiasisAscariasis
Inactive IndicationsGastrointestinal NeoplasmsNeoplasmsNecatoriasis +[6] 

Other Information

ATC CodeP02CA01
Related LinksWikipediaDrugBankKEGG